Clinical and angiography factors influencing long-term coronary stenting results
Abstract
Aim. To study long-term results of coronary artery (CA) stenting, according to baseline clinical and coronaroangiography (CAG) data.
Material and methods. The study included 66 males who underwent coronary stent implantation. One to three years later, all participants were retrospectively divided into several groups. Patients without coronary events (CE) comprised CE- Group (n=44), patients with CE – CE+ Group (n=22). Second CAG was performed in 49 patients with 56 stent-implanted CA. CAG signs of restenosis were not found in 35 stenting cases (Restenosis- Group), being registered in 21 stenting cases (Restenosis+ Group). Stepwise multiple regression was used for analyzing the results obtained.
Results. After stent implantation, CE risk was affected by smoking status, number of hemodynamically significant stenoses, low diameter of stented CA, balloon inflation time, and minimal effective intervention (MEI) level. Restenosis risk was linked to unstable angina presence, serum triglycerides level, stenosis type, MEI, and low increase in CA diameter after stenting.
Conclusion. In selecting treatment tactics for coronary heart disease patients, and assessing the risk of adverse outcomes after CA stenting, a complex of factors affecting CE and restenosis rates should be taken into account, as well as minimally traumatic technique of coronary stenting should be used.
About the Authors
S. O. Sokolova
State Research Center for Preventive Medicine, Ministry of Health of the Russian Federation, Moscow
Russian Federation
Russian Federation
V. P. Mazaev
State Research Center for Preventive Medicine, Ministry of Health of the Russian Federation, Moscow
Russian Federation
Russian Federation
I. G. Shiman
State Research Center for Preventive Medicine, Ministry of Health of the Russian Federation, Moscow
Russian Federation
Russian Federation
Yu. M. Popov
State Research Center for Preventive Medicine, Ministry of Health of the Russian Federation, Moscow
Russian Federation
Russian Federation
S. V. Ryazanova
State Research Center for Preventive Medicine, Ministry of Health of the Russian Federation, Moscow
Russian Federation
Russian Federation
G. V. Kuznetsova
State Research Center for Preventive Medicine, Ministry of Health of the Russian Federation, Moscow
Russian Federation
Russian Federation
References
1. Finci L, Kobayashi N, Ferraro M, et al. Results of coronary stenting with different indications. CVI 2000; 5: 8-12.
2. Lakovou I, Schmidt T, Bonizzoni E, et al. Incidens, predictors, and outcome of thrombosis after successful implantation of drugeluting stents. JAMA 2005; 293: 2126-30.
3. Allen DM, Candy FB. Analyzing Experimented Data by Regression. Belmont CA, Lifetime Learning Publication. 1982.
4. Degertekin M, Regar E, Tanabe K, et al. Sirolimus eluting stent in the treatment of atherosclerosis coronary artery disease. Minerva Cardioangiol 2002; 50(5): 405-18.
5. Fajadet J, Morice MC, Bode C, et al. Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial. Circulation 2005; 111(8): 1040-4.
6. Ruygrok PN, Webster MWI, Valk V, et al. Clinical and angiographic factors associated with asymptomatic restenosis after percutaneous coronary intervention. Circulation 2001; 104: 2289-94.
7. Heper G. The comparison of different clinical, laboratory, and angiographical parameters in diabetic stent restenosis. Heart Dis 2002; 4(3): 139-40.
8. Аронов Д.М. Лечение и профилактика атеросклероза. Москва 2000.
9. Бабунашвили А.М., Иванов В.А., Бирюков С.А. Эндопротезирование (стентирование) венечных артерий сердца. Монография-М «АСВ» 2000; 704 с.
10. Tanguay JF, Hammoud T, Geoffroy P, et al. Chronic platelet and neutrophil adhesion: a causal role for neointimal hyperplasia in in-stent restenosis. J Endovasc Ther 2003; 10(5): 968-77.
11. Fukuda D, Shimada K, Tanaka A, et al. Circulation monocytes and in-stent neointima after coronary stent implantation. JACC 2004; 43(1):18-23.
12. Kastrati A, Shomig A, Elezi S, et al. Prognostic value of the modified American College of Ccardiology/American Heart Association stenosis morphology classification for long-term angiographic and clinical outcome after coronary stent placement. Circulation 1999; 100: 1285-90.
13. Briguori C, Nishida T, Adamian M, et al. Coronary stenting versus balloon angioplasty in small coronary artery with complex lesions. Catheter Cardiovasc Interv 2000; 50(4): 390-7.
14. Figal DA, Chavarri M, Candel J, et al. Intracoronary stents in small vessels: short- and long-term clinical results. Rev Esp Cardiol 2000; 53(88): 1040-6.
15. Cutlip DE, Chauhan MS, Baim DS, et al. Clinical restenosis after coronary stenting; perspectives from multicenter clinical trials. JACC 2002; 40(12): 2082-9.
16. Foley DP, Pieper M, Wijns W, et al. The influence of stent length on clinical and angiographic outcome in patients undergoing elective stenting for native coronary artery lesions. Eur Heart J 2001; 22: 1585-93.
17. Hoffman R, Haager P, Mintz GS, et al. The impact of high pressure vs low pressure stent implantation on intimal hyperplasia and follow-up lumen dimensions; results of a randomized trial. Eur Heart J 2001; 22(21); 2015-24.
18. Manolis AS. Reduced incidence of clinical restenosis with newer generation stents, stent oversizing, and high-pressure deployment: single-operator experience. Clin Cardiol 2001; 24(2); 119-26.
19. Wen S, Mao J, Guo L. Multivariate analysis of clinical factors in restenosis after coronary interventional treatment. Zhonghua Yi Xue Za Zhi 1999; 79(3): 197-9.
Review
For citations:
Sokolova S.O., Mazaev V.P., Shiman I.G., Popov Yu.M., Ryazanova S.V., Kuznetsova G.V. Clinical and angiography factors influencing long-term coronary stenting results. Cardiovascular Therapy and Prevention. 2005;4(4):46-54. (In Russ.)
Views:
436
Email this article 
